BTBD19 promotes colorectal cancer progression and correlates with adverse clinical outcomes
BTBD19 is upregulated in CRC and promotes tumor progression. It may serve as a potential prognostic biomarker for CRC, with implications for understanding CRC pathogenesis and immune microenvironment regulation.
Authors
- Zihan Zhao (ORCID: https://orcid.org/0000-0002-7013-4405)
- Changjiang Yang
- Xuhua Geng (ORCID: https://orcid.org/0009-0009-9240-1293)
Institutions
- Boston University (US)
- Peking University (CN)
- Aerospace Center Hospital (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.3389/fonc.2025.1685601
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00